ListedSMEPharmaceuticals & DrugsGOLDLINE
Goldline Pharmaceutical IPO
Goldline Pharmaceutical IPO is a sme IPO raising ₹12 Cr at ₹41 – ₹43 a share. It listed on 19 May 2026 and trades at ₹37 today, −13.0% against its issue price of ₹43. It was subscribed 0.00× in total.
₹43
Issue price
₹37
Price now
−13.0%
Since issue price
19 May 2026
Listed on
0.00×Subscribed (final) · all exchanges
No bids yet
populated partly populated we hold nothing here — the tab says why
Source documents
What the issuer and the exchanges published. Everything else on this tab is read out of these.
Read-out of the prospectus
A severity-ranked risk register with every item cited to its page, plus litigation counts and rupee exposure and related-party dealings, are being built from the prospectus above. We read prospectuses for current and upcoming issues — historical issues will not gain these sections.